Hospira Boosts Antibiotic Business with Acquisition of Orchid’s API Facilities
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 9 (Table of Contents)
Published: 5 Sep-2012
DOI: 10.3833/pdr.v2012.i9.1802 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Hospira has agreed to acquire Orchid Chemicals & Pharmaceuticals’ penicillin and penem API business, including an API manufacturing plant and an associated R&D facility, for approximately US$200 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS